Enlon (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Enlon drug offered from Mylan Institutional LLC. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: edrophonium chloride
SUBSTANCE NAME: EDROPHONIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-22
END MARKETING DATE: 0000-00-00


Enlon HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEnlon from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2013-04-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-190_91687c49-8f28-499e-9999-9b51154ad379
PRODUCT NDC: 67457-190
APPLICATION NUMBER: ANDA088873

Other EDROPHONIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional LLCEnlon